v3.26.1
Equity Incentive Plans and Warrants (Tables)
6 Months Ended
Jun. 30, 2026
Equity Incentive Plans and Warrants [Abstract]  
Stock Option Plans Activity
Activity under the Company’s stock option plans for the six months ended June 30, 2026 was as follows:
 
 
 
Number
of
options
 
 
Weighted
average
exercise
price
 
 
Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2025
 
 
191,552
 
 
$
29.36
 
 
 
92,127
 
Granted
 
 
11,280
 
 
 
6.70
 
 
 
2,045
 
Forfeited
 
 
(34,226
)
 
 
26.90
 
 
 
 
 
Outstanding at June 30, 2026
 
 
168,606
 
 
$
28.34
 
 
$
2,045
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vested and exercisable at June 30, 2026
 
 
98,295
 
 
$
36.52
 
 
$
 
Black-Scholes Weighted Average Assumptions
The Black-Scholes weighted-average assumptions for stock option awards granted to employees and nonemployees for the six months ended June 30, 2026 were as follows:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Six Months Ended
June 30, 2026
 
 
 
Employees
 
 
Nonemployees
 
 
 
2021
Plan
 
 
Inducement
Grants
 
 
2021
Plan
 
Options Granted
 
 
6,000
 
 
 
16,750
 
 
 
5,280
 
Fair Value of Awards
 
$
5.53
 
 
 
7.36
 
 
$
5.05
 
Exercise Price
 
$
6.92
 
 
 
9.28
 
 
$
6.45
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expected term (in years)
 
 
6.25
 
 
 
6.25
 
 
 
5.67
 
Risk‑free interest rate
 
 
4.15
%
 
 
3.83
%
 
 
4.10
%
Dividend yield
 
 
%
 
 
%
 
 
%
Expected volatility
 
 
96.38
%
 
 
96.84
%
 
 
97.40
%
Restricted Stock Units (RSUs)
Restricted stock units were granted to employees in the first quarter of 2026 with service-based vesting conditions. Related activity during the six months ended June 30, 2026 was as follows:
 
 
 
 
 
 
 
 
 
 
 
Number
of
RSUs
 
 
Weighted
average
grant
date
fair value
 
Outstanding at December 31, 2025
 
 
 
 
$
 
Granted
 
 
71,750
 
 
 
10.85
 
Forfeited
 
 
(1,025
)
 
 
10.40
 
Outstanding at June 30, 2026
 
 
70,725
 
 
$
10.85
 
Share-based Compensation Expense
The following table shows the share-based compensation expense related to stock option and RSU grants to employees and nonemployees by financial statement line item on the accompanying condensed statements of operations and comprehensive loss:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended June 30,
 
 
Six Months Ended June 30,
 
 
 
2026
 
 
2025
 
 
2026
 
 
2025
 
Research and development
 
$
35,744
 
 
 
68,299
 
 
 
64,681
 
 
 
205,223
 
Sales and marketing
 
 
22,529
 
 
 
21,418
 
 
 
38,453
 
 
 
10,987
 
General and administrative
 
 
152,547
 
 
 
92,254
 
 
 
259,294
 
 
 
332,998
 
Total share-based compensation expense
 
$
210,820
 
 
 
181,971
 
 
 
362,428
 
 
 
549,208
 
 
Share-based compensation expense by award type during the three and six months ended June 30, 2026 and 2025 was as follows:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended June 30,
 
 
Six Months Ended June 30,
 
 
 
2026
 
 
2025
 
 
2026
 
 
2025
 
Stock options
 
 
110,462
 
 
 
167,087
 
 
 
217,337
 
 
 
534,324
 
ESPP
 
 
6,636
 
 
 
14,884
 
 
 
6,636
 
 
 
14,884
 
Restricted stock units
 
 
93,722
 
 
 
 
 
 
138,455
 
 
 
 
Total share-based compensation expense
 
$
210,820
 
 
 
181,971
 
 
 
362,428
 
 
 
549,208
 
Inducement Grants [Member]  
Equity Incentive Plans and Warrants [Abstract]  
Stock Option Plans Activity
The inducement grants are summarized as follows:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number
of
options
 
 
Weighted
average
exercise
price
 
 
Weighted
average
remaining
life years
 
Outstanding at December 31, 2025
 
 
6,875
 
 
$
50.40
 
 
 
4.53
 
Granted
 
 
16,750
 
 
 
9.28
 
 
 
9.69
 
Forfeited
 
 
(1,875
)
 
 
26.40
 
 
 
 
Outstanding at June 30, 2026
 
 
21,750
 
 
$
20.80
 
 
 
8.77
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vested and exercisable at June 30, 2026
 
 
5,000
 
 
$
59.40
 
 
 
5.66